XML 30 R11.htm IDEA: XBRL DOCUMENT v3.19.3
Intangible Assets and Goodwill
9 Months Ended
Sep. 30, 2019
Intangible Assets and Goodwill  
Intangible Assets and Goodwill

Note 4 – Intangible Assets and Goodwill

Intangible assets consist of the following at:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$'s in 000's

 

 

 

 

 

Useful Lives

 

 

 

September 30, 2019

 

December 31, 2018

Amortizable intangibles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Distribution agreement

 

 

 

 

 

2 years

 

 

 

$

3,021

 

$

3,021

Certification

 

 

 

 

 

7 years

 

 

 

 

350

 

 

350

Customer relationships

 

 

 

 

 

12-20 years

 

 

 

 

89,159

 

 

82,124

Patents and processes

 

 

 

 

 

10 years

 

 

 

 

4,804

 

 

1,900

Brand names

 

 

 

 

 

10-15 years

 

 

 

 

14,963

 

 

10,470

Total amortizable intangibles

 

 

 

 

 

 

 

 

 

 

112,297

 

 

97,865

Less accumulated amortization

 

 

 

 

 

 

 

 

 

 

(14,131)

 

 

(9,835)

Total net amortizable intangibles

 

 

 

 

 

 

 

 

 

 

98,166

 

 

88,030

Non-amortizable intangibles

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Trademarks and other

 

 

 

 

 

 

 

 

 

 

18,016

 

 

516

In-process research and development

 

 

 

 

 

 

 

 

 

 

5,539

 

 

 -

Intangible assets, net of accumulated amortization

 

 

 

 

 

 

 

 

 

$

121,721

 

$

88,546

 

Certain intangible assets are denominated in currencies other than the U.S. Dollar; therefore, their gross and net carrying values are subject to foreign currency movements. Amortization expense for the three months ended 2019 and 2018 was $1.8 million and $1.3 million, respectively, and $4.4 million and $3.7 million for the nine months ended September 30, 2019 and 2018, respectively.

The in-process research and development (“IPRD”), intangible assets represent the value assigned to acquired R&D projects that principally represent rights to develop and sell a product that the Company has acquired which have not yet been completed or approved. The IPRD acquired as part of the Perrigo Animal Health Acquisition is accounted for as an indefinite-lived asset until the product is available for sale and regulatory approval is obtained, or abandonment of the associated research and development efforts. If the research and development efforts are successfully completed, the IPRD would be amortized over its then estimated useful life. The fair value of the IPRD was estimated using the multi-period excess earnings income method. The projected cash flows estimates for the future products were based on certain key assumptions including estimates of future revenues and expenses, taking into account the stage of development at the acquisition date and the resources needed to complete development.

Estimated future amortization expense for each of the following years is as follows:

 

 

 

 

 

 

 

 

Years ending December 31,  ($'s in 000's)

 

 

 

 

 

 

Remainder of 2019

 

 

 

 

$

1,807

2020

 

 

 

 

 

8,974

2021

 

 

 

 

 

8,962

2022

 

 

 

 

 

9,151

2023

 

 

 

 

 

8,793

Thereafter

 

 

 

 

 

60,479

 

The following is a summary of the changes in the carrying value of goodwill for the period from January 1, 2018 to September 30,  2019:

 

 

 

 

 

 

 

 

 

 

 

 

Reporting Unit

 

 

 

($'s in 000's)

 

Products

 

Services

 

Total

Goodwill as of January 1, 2018

 

$

5,064

 

$

 —

 

$

5,064

Foreign currency translation

 

 

(285)

 

 

 —

 

 

(285)

Acquisitions

 

 

72,986

 

 

47,264

 

 

120,250

Goodwill as of December 31, 2018

 

 

77,765

 

 

47,264

 

 

125,029

Foreign currency translation

 

 

(134)

 

 

 —

 

 

(134)

Acquisitions

 

 

106,869

 

 

 —

 

 

106,869

Goodwill as of September 30, 2019

 

$

184,500

 

$

47,264

 

$

231,764